# OnCo record skin-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/skin-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "skin-cancer" ;
  schema:name "Skin cancer (all types)"@en ;
  schema:alternateName "Skin Cancer"@en, "Skin cancers"@en, "Cutaneous malignancies"@en, "Keratinocyte cancer"@en, "Non-melanoma skin cancer"@en, "NMSC"@en, "Skin carcinoma"@en, "Cancer of the skin"@en, "C44"@en, "C43"@en ;
  schema:description "Skin cancer covers the very common and rarely dangerous basal cell and squamous cell carcinomas, the less common but more serious melanoma, and rarer tumours such as Merkel cell carcinoma and Kaposi sarcoma. Almost all of it is caused by ultraviolet light and most of it is found and cured by simple surgery."@en ;
  schema:url <https://onco.cc/cancers/skin-cancer/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Skin_cancer> ;
  schema:citation <https://www.cancer.gov/types/skin>, <https://doi.org/10.3322/caac.21660>, <https://www.nhs.uk/conditions/non-melanoma-skin-cancer/>, <https://www.nhs.uk/conditions/non-melanoma-skin-cancer/treatment/>, <https://www.nhs.uk/conditions/scars/>, <https://www.nhs.uk/live-well/seasonal-health/sunscreen-and-sun-safety/>, <https://www.nhs.uk/conditions/sunburn/>, <https://www.nhs.uk/conditions/sepsis/>, <https://www.nhs.uk/nhs-services/urgent-and-emergency-care-services/when-to-use-111/>, <https://www.nhs.uk/nhs-services/urgent-and-emergency-care-services/when-to-call-999/>, <https://www.skinhealthinfo.org.uk/condition/basal-cell-carcinoma/>, <https://www.skinhealthinfo.org.uk/condition/squamous-cell-carcinomas/>, <https://www.skinhealthinfo.org.uk/condition/mohs-micrographic-surgery/>, <https://www.skinhealthinfo.org.uk/condition/skin-cancer-in-organ-transplant-recipients/>, <https://www.skinhealthinfo.org.uk/sun-awareness/the-sunscreen-fact-sheet/>, <https://doi.org/10.1111/bjd.20524>, <https://doi.org/10.1111/bjd.19621>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/treatment/surgery/treatment-surgery-types>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/treatment/surgery/problems-after-surgery>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/treatment/surgery/mohs-micrographic-surgery-mms>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/treatment/follow-up-appointments>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/living-with/skin-care-after-skin-cancer>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/living-with/coping>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/getting-diagnosed/referral-specialist>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/treatment/photodynamic-therapy>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/treatment/chemotherapy-cream>, <https://www.macmillan.org.uk/cancer-information-and-support/skin-cancer>, <https://www.changingfaces.org.uk/>, <https://doi.org/10.1002/14651858.CD003412.pub3>, <https://doi.org/10.1016/S1470-2045(13)70530-8>, <https://doi.org/10.1016/j.jid.2016.10.019>, <https://doi.org/10.1016/S1470-2045(13)70143-8>, <https://doi.org/10.1016/j.jid.2017.09.033>, <https://doi.org/10.1016/j.ejca.2014.08.018>, <https://doi.org/10.1001/archderm.136.12.1524>, <https://doi.org/10.1016/S1470-2045(08)70178-5>, <https://doi.org/10.1001/jamadermatol.2013.2139>, <https://doi.org/10.1136/bmj.f6153>, <https://doi.org/10.1002/ijc.27765>, <https://doi.org/10.1001/jamadermatol.2016.4920>, <https://doi.org/10.3390/cancers17243921>, <https://doi.org/10.1038/s41598-024-67740-0>, <https://doi.org/10.3390/healthcare14172833>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/types>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/about-skin-cancer>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/stages-grades>, <https://www.cancerresearchuk.org/about-cancer/skin-cancer/survival>, <https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/non-melanoma-skin-cancer/incidence>, <https://www.nhs.uk/conditions/non-melanoma-skin-cancer/symptoms/>, <https://www.rcpath.org/resourceLibrary/g123-dataset-basal.html>, <https://www.rcpath.org/resourceLibrary/g124datasetsquamous-pdf.html>, <https://www.rcpath.org/resourceLibrary/basal-cell-tnm9.html>, <https://doi.org/10.1111/bjd.16892>, <https://doi.org/10.1111/bjd.17873>, <https://doi.org/10.1002/ski2.61>, <https://doi.org/10.1093/bjd/ljag315>, <https://doi.org/10.1093/bjd/ljad033>, <https://doi.org/10.1093/bjd/ljaf352>, <https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/methodologies/cancerregistrationstatisticsqmi>, <https://doi.org/10.2340/actadv.v104.40601>, <https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer>, <https://www.england.nhs.uk/wp-content/uploads/2018/04/B1350_Skin-cancer-timed-diagnostic-pathway.pdf>, <https://www.nice.org.uk/guidance/csg8>, <https://gettingitrightfirsttime.co.uk/wp-content/uploads/2021/09/DermatologyReport-Sept21o.pdf>, <https://www.nice.org.uk/guidance/ng34/chapter/Recommendations> ;
  onco:tag "umbrella" ;
  onco:related <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/basal-cell-carcinoma/>, <https://onco.cc/cancers/cutaneous-scc/>, <https://onco.cc/cancers/merkel-cell-carcinoma/>, <https://onco.cc/cancers/kaposi-sarcoma/>, <https://onco.cc/cancers/uveal-melanoma/>, <https://onco.cc/cancers/bowens-disease/>, <https://onco.cc/cancers/dermatofibrosarcoma-protuberans/>, <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/dermoscopy-ai/>, <https://onco.cc/technologies/psycho-oncology/>, <https://onco.cc/technologies/peer-support-groups/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/multidisciplinary-tumour-board/>, <https://onco.cc/technologies/chemoprevention/>, <https://onco.cc/technologies/financial-navigation/>, <https://onco.cc/technologies/cbt-fatigue-distress/>, <https://onco.cc/technologies/palliative-care/> ;
  onco:targets <https://onco.cc/targets/braf/>, <https://onco.cc/targets/mek/>, <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/cemiplimab/>, <https://onco.cc/drugs/dabrafenib/>, <https://onco.cc/drugs/vismodegib/> ;
  onco:institutions <https://onco.cc/institutions/melanoma-focus/>, <https://onco.cc/institutions/skcin/>, <https://onco.cc/institutions/british-association-of-dermatologists/>, <https://onco.cc/institutions/guys-st-thomas/>, <https://onco.cc/institutions/leeds-cancer-centre/>, <https://onco.cc/institutions/newcastle-cancer-centre/>, <https://onco.cc/institutions/addenbrookes-cambridge/>, <https://onco.cc/institutions/birmingham-cancer-centre/>, <https://onco.cc/institutions/velindre-cardiff/> ;
  onco:terms <https://onco.cc/terms/mohs-surgery/>, <https://onco.cc/terms/wide-local-excision/>, <https://onco.cc/terms/perineural-invasion/>, <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/quality-of-life/>, <https://onco.cc/terms/curative-intent/>, <https://onco.cc/pathways/field-cancerisation/>, <https://onco.cc/terms/keratinocyte-cancer/>, <https://onco.cc/terms/actinic-keratosis/>, <https://onco.cc/terms/keratinocyte-cancer-counting/>, <https://onco.cc/terms/bcc-growth-pattern/>, <https://onco.cc/terms/cscc-subtype-and-grade/>, <https://onco.cc/terms/tnm-skin-carcinoma/>, <https://onco.cc/terms/bwh-staging-cscc/>, <https://onco.cc/terms/skin-cancer-high-risk-features/>, <https://onco.cc/terms/keratoacanthoma/>, <https://onco.cc/terms/inherited-skin-cancer-syndromes/>, <https://onco.cc/terms/carcinoma-in-situ/>, <https://onco.cc/terms/resection-margins/>, <https://onco.cc/terms/surgical-margins-keratinocyte-cancer/>, <https://onco.cc/terms/curettage-and-cautery/>, <https://onco.cc/terms/topical-and-destructive-treatment-bcc/>, <https://onco.cc/terms/radiotherapy-for-skin-cancer/>, <https://onco.cc/terms/hedgehog-inhibitor-tolerability/>, <https://onco.cc/terms/skin-cancer-after-organ-transplant/> ;
  onco:trials <https://onco.cc/trials/mohs-versus-excision-facial-bcc/>, <https://onco.cc/trials/sins-trial/>, <https://onco.cc/trials/mal-pdt-imiquimod-fluorouracil-superficial-bcc/>, <https://onco.cc/trials/avril-surgery-versus-radiotherapy-bcc/>, <https://onco.cc/trials/trog-05-01/>, <https://onco.cc/trials/c-post/>, <https://onco.cc/trials/molemate/>, <https://onco.cc/trials/mcc-rational-treatment/>, <https://onco.cc/trials/impact-bcc/>, <https://onco.cc/trials/spot-it/>, <https://onco.cc/trials/scc-after/> ;
  onco:people <https://onco.cc/people/hywel-williams/>, <https://onco.cc/people/nick-levell/> ;
  onco:pipeline <https://onco.cc/drugs/fianlimab/>, <https://onco.cc/drugs/lifileucel/> ;
  onco:standardOfCare <https://onco.cc/terms/skin-graft-and-flap-reconstruction/>, <https://onco.cc/terms/facial-scar-after-skin-cancer/>, <https://onco.cc/terms/mohs-surgery/>, <https://onco.cc/terms/wide-local-excision/>, <https://onco.cc/terms/curettage-and-cautery/>, <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/mohs-surgery/>, <https://onco.cc/terms/skin-graft-and-flap-reconstruction/>, <https://onco.cc/terms/wide-local-excision/>, <https://onco.cc/terms/curative-intent/>, <https://onco.cc/technologies/multidisciplinary-tumour-board/>, <https://onco.cc/terms/sun-protection-after-skin-cancer/>, <https://onco.cc/terms/second-primary-skin-cancer/>, <https://onco.cc/terms/skin-cancer-after-organ-transplant/>, <https://onco.cc/technologies/chemoprevention/>, <https://onco.cc/pathways/field-cancerisation/>, <https://onco.cc/terms/facial-scar-after-skin-cancer/>, <https://onco.cc/terms/second-primary-skin-cancer/>, <https://onco.cc/technologies/psycho-oncology/>, <https://onco.cc/technologies/peer-support-groups/>, <https://onco.cc/terms/quality-of-life/>, <https://onco.cc/technologies/cbt-fatigue-distress/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/terms/skin-cancer-after-organ-transplant/>, <https://onco.cc/terms/second-primary-skin-cancer/>, <https://onco.cc/terms/sun-protection-after-skin-cancer/>, <https://onco.cc/technologies/chemoprevention/>, <https://onco.cc/pathways/field-cancerisation/>, <https://onco.cc/technologies/multidisciplinary-tumour-board/>, <https://onco.cc/terms/surgical-margins-keratinocyte-cancer/>, <https://onco.cc/terms/resection-margins/>, <https://onco.cc/terms/mohs-surgery/>, <https://onco.cc/technologies/dermoscopy-ai/>, <https://onco.cc/terms/surgical-margins-keratinocyte-cancer/>, <https://onco.cc/terms/mohs-surgery/>, <https://onco.cc/terms/radiotherapy-for-skin-cancer/>, <https://onco.cc/trials/mohs-versus-excision-facial-bcc/>, <https://onco.cc/terms/mohs-surgery/>, <https://onco.cc/terms/surgical-margins-keratinocyte-cancer/>, <https://onco.cc/terms/curettage-and-cautery/>, <https://onco.cc/terms/surgical-margins-keratinocyte-cancer/>, <https://onco.cc/terms/radiotherapy-for-skin-cancer/>, <https://onco.cc/trials/avril-surgery-versus-radiotherapy-bcc/>, <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/technologies/electron-beam-therapy-systems/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/terms/sentinel-lymph-node-biopsy/>, <https://onco.cc/technologies/checkpoint-inhibitor/> .